Endometriosis CARE Act
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Endometriosis CARE Act (H.R. 8565) is a health-related bill introduced in the 118th Congress aimed at addressing issues related to endometriosis. The bill was referred to the House Subcommittee on Health but did not advance further and ultimately failed or expired. There is no official summary or full text available for detailed analysis. The bill falls within the health policy area and appears to focus on care or research related to endometriosis, a medical condition affecting many individuals.
H.R. 8565 sought to address endometriosis-related health concerns but did not progress beyond referral to a subcommittee and expired without enactment.
- The bill is titled the Endometriosis CARE Act and was introduced in the House of Representatives during the 118th Congress.
- It was referred to the Subcommittee on Health on May 31, 2024, but no further legislative action was recorded.
- The bill is categorized under the health policy area and is currently marked as failed or expired.
['Individuals affected by endometriosis who may receive improved care or attention if the bill had provisions for treatment or research.', "Health agencies and organizations involved in women's health or chronic disease management that might have been engaged through the bill's implementation."]
['Lack of available full text and official summary limits understanding of specific provisions, funding mechanisms, or enforcement details.', 'Since the bill expired without passage, any intended programs or funding were not authorized, which may affect stakeholders expecting support.', 'Potential implementation challenges or costs cannot be assessed due to missing detailed legislative language.']
The bill was introduced in the 118th Congress and referred to the House Subcommittee on Health but did not advance further. Its failure to progress suggests limited legislative momentum or prioritization within the health policy agenda during this session.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['The failure of the bill to pass may delay or reduce federal focus and resources on endometriosis-related health issues.', 'Stakeholders may need to seek alternative legislative or policy avenues to address endometriosis care and research.', 'Public awareness efforts around endometriosis might be impacted by the absence of new legislative support.']
The absence of an official summary and full bill text limits the ability to conduct a thorough transparency and oversight analysis. The bill's expiration without further action highlights the importance of tracking legislative progress to understand which health issues receive federal attention. Future monitoring of related bills or initiatives is recommended to assess ongoing government response to endometriosis.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.